BioNTech returns to profit in third quarter, raises revenue outlook
BioNTech reported a net profit of $206.5 million for the third quarter, supported by reduced legal expenses offsetting lower vaccine sales.
BioNTech reported a net profit of $206.5 million for the third quarter, supported by reduced legal expenses offsetting lower vaccine sales.